A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors

References

• Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. The Lancet. 2003;362(9377):22–29.10.1016/S0140-6736(03)13802-0
   PubMed Web of Science ®Google Scholar
• Barber TJ, Hughes A, Dinsmore WW, Phillips A. How does HIV impact on non-AIDS events in the era of HAART?. Int J STD AIDS. 2009;20(1):1–3.10.1258/ijsa.2008.008302
   PubMed Web of Science ®Google Scholar
• Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506–2512.10.1210/jc.2006-2190
   PubMed Web of Science ®Google Scholar
• Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44:1625–1631.10.1086/518285
   PubMed Web of Science ®Google Scholar
• Phillips AN, Carr A, Neuhaus J, et al. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther. 2008;13(2):177–187.
   PubMed Web of Science ®Google Scholar
• Lundgren JD, Reiss P, Worm SW, et al. Risk of myocardial infarction with exposure to specific ARV from the PI, NNRTI, and NRTI drug classes: the D:A:D study. CROI, Montreal, 2009.
   Google Scholar
• Kundur A, Singh I, Bulmer A. Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert’s syndrome? Atherosclerosis. 2015;239(1):73–84.10.1016/j.atherosclerosis.2014.12.042
   PubMed Web of Science ®Google Scholar
• Mazzone GL, Rigato I, Ostrow JD, et al. Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules. Biochem Biophys Res Commun. 2009;386:338–344.10.1016/j.bbrc.2009.06.029
   PubMed Web of Science ®Google Scholar
• Basiglio CL, Arriaga SM, Pelusa F, Almara AM, Kapitulnik J, Mottino AD. Complement activation and disease: protective effects of hyperbilirubinaemia. Clin Sci. 2010;118:99–11310. doi:10.1042/CS20080540.
   Web of Science ®Google Scholar
• Vítek L, Malíková I, Kvasnička J, Benáková H, Novotný L. Relationship between serum bilirubin and markers of inflammation and oxidative stress. J Gastroenterol Hepatol. 2007;22:A235–A235. doi:10.1111/j.1440-1746.2006.04564.x.
   Web of Science ®Google Scholar
• Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med. 2011;49:1823–1828. doi:10.1515/cclm.2011.662.
   PubMed Web of Science ®Google Scholar
• Yoshino S, Hamasaki S, Ishida S, et al. Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients. J Atheroscler Thromb. 2011;18:403–412. doi:10.5551/jat.6346.
   PubMed Web of Science ®Google Scholar
• Yoshino S, Hamasai S, Ishida S, et al. Effect of serum concentration of bilirubin in the obese patients: the action for coronary endothelial function and inflammatory stress. J Am Coll Cardiol. 2010;55:E1434.
   Google Scholar
• Erdogan D, Gullu H, Yildirim E, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006;184(2):431–437.10.1016/j.atherosclerosis.2005.05.011
   PubMed Web of Science ®Google Scholar
• Scourfield A, Waters L, Jones R, et al. The use of calcaneal stiffness index to screen for osteoporosis in HIV-infected individuals. 17th Annual BHIVA Conference, 6–8 April 2011, Bournemouth. Oral abstract O33.
   Google Scholar
• D:A:D Study Group. The use of the Framingham equation to predict myocardial infarctions in HIV infected patients: comparison with observed events in the D:A:D Study. HIV Med. 2006 May;7(4):218–230.
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Delaney J, Wanke C, FRAM Study. HIV infection is an independent risk factor for atherosclerosis similar in magnitude to traditional cardiovascular disease risk factors, CROI 2009, abstract 146.
   Google Scholar
• Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15.10.1161/hy0102.099031
   PubMed Web of Science ®Google Scholar
• Mattace-Raso F, van der Cammen TJM, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the rotterdam study. Circulation. 2006;113:657–663.10.1161/CIRCULATIONAHA.105.555235
   PubMed Web of Science ®Google Scholar
• Guo W, Liao C, Zou Y, et al. Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies. J Sex Med. 2010;7(8):2805–2816.
   Google Scholar
• Hall SA, Shackelton R, Rosen RC, Araujo AB. Sexual activity, erectile dysfunction, and incident cardiovascular events. Am J Cardiol. 2010Jan 15;105(2):192–197.10.1016/j.amjcard.2009.08.671
   PubMed Web of Science ®Google Scholar
• Chew KK, Finn J, Stuckey B, et al. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med. 2010 Jan;7:192–202.
   PubMed Web of Science ®Google Scholar
• Araujo AB, Hall SA, Ganz P, et al. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the framingham risk score? J Am Coll Cardiol. 2010 Jan 26;55(4):350–356.10.1016/j.jacc.2009.08.058
   PubMed Web of Science ®Google Scholar
• Dao C, Young B, Buchacz K, Baker R, Brooks J. The HIV Outpatient Study Investigators. Higher and increasing rates of fracture among HIV-infected persons in the HIV outpatient study compared to the general US population, 1994 to 2008. Program of the 17th Conference of Retrovirus and Opportunistic Infections 2010, San Franciso. Oral 128.
   Google Scholar
• McComsey G, Kitch D, Daar E, et al. Bone and limb fat outcomes of ACTG A5224s, a substudy of ACTG A5202: a prospective, randomized, partially blinded phase III trial of ABC/3TC or TDF/FTC with EFV or ATV/r for initial treatment of HIV-1 infection. Program of the 17th Conference on Retroviruses and Opportunistic Infections 2010, San Franciso. Abstract 106LB.
   Google Scholar
• Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254–1259.10.1136/bmj.312.7041.1254
   PubMed Web of Science ®Google Scholar
• Stein JH, Hodis HN, Brown TT, et al. Prospective Randomized clinical trial of the effects of three modern antiretroviral therapies on carotid intima-media thickness in HIV-infected individuals (ACTG A5260s). J Am Coll Cardiol. 2014;63(12_S).
   Web of Science ®Google Scholar
• Asboe D, Catalan J, Mandalia S, et al. Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care. 2007 Sep;19(8):955–965.10.1080/09540120701209847
   PubMed Web of Science ®Google Scholar
• Rosen RC, Cappelleri JC, Gendrano N. The international index of erectile function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226–244.10.1038/sj.ijir.3900857
   PubMed Web of Science ®Google Scholar
• Coyne K, Mandalia S, McCullough S, et al. The international index of erectile function: development of an adapted tool for use in HIV-positive men who have sex with men. J Sex Med. 2010 Feb;7(2 Pt 1):769–774.
   Google Scholar
• www.europeanaidsclinicalsociety.org/guidelinespdf/2_Non_Infectious_Co_Morbidities_in_HIV.pdf.
   Google Scholar
• Hans D, Dargent-Molina P, Schoot AM, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. The Lancet. 1996;348:511–514.10.1016/S0140-6736(95)11456-4
   PubMed Web of Science ®Google Scholar
• Krieg M-A, Cornuz J, Ruffieux C, et al. Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women >=70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. JBMR. 2006;21(9):1457–1463.
   Web of Science ®Google Scholar
• Glüer CC, Eastell R, Reid DM, et al. Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS study. JBMR. 2004;19(5):782–793.
   Web of Science ®Google Scholar
• Frediani B, Acciai C, Falsetti P, et al. Calcaneus ultrasonometry and dual-energy X-Ray absorptiometry for the evaluation of vertebral fracture risk. Calcif Tissue Int. 2006;79:223–229.10.1007/s00223-005-0098-4
   PubMed Web of Science ®Google Scholar
• Hartl F, Tyndall A, Kraenzlin M, et al. Discriminatory ability of quantitative ultrasound parameters and bone mineral density in a population-based sample of postmenopausal women with vertebral fractures: results of the basel osteoporosis study. J Bone Miner Res. 2002 Feb;17(2):321–330.10.1359/jbmr.2002.17.2.321
   PubMed Web of Science ®Google Scholar